Literature DB >> 20535714

Serum testosterone and short-term mortality in men with acute myocardial infarction.

Constantin Militaru1, Ionut Donoiu, Ovidiu Dracea, Dan-Dominic Ionescu.   

Abstract

BACKGROUND: A significant and independent association between testosterone levels and coronary events in men and women has not been confirmed in large prospective studies, although some reports have shown that endogenous testosterone concentrations in men are inversely related to cardiovascular and general mortality.
METHODS: We aimed to assess the relationship between serum testosterone level and short-time (30-day) mortality in men with acute myocardial infarction.
RESULTS: We included 126 consecutive male patients admitted with acute myocardial infarction. The mean age was 62 +/- 13 years. We determined, at admission, serum free testosterone (T) level (using a chemoluminiscence assay), high sensitivity C-reactive protein, N-terminal pro-B-type natriuretic peptide, and glycated hemoglobin level. We analyzed the 30-day mortality.
CONCLUSIONS: The mean level of serum T was 4.1 +/- 2.9 ng/mL. All non-survivors had T level < or = 3 ng/mL. A low level of T was independently related to total short-term mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20535714

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  13 in total

Review 1.  Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.

Authors:  Andre B Araujo; Julia M Dixon; Elizabeth A Suarez; M Hassan Murad; Lin T Guey; Gary A Wittert
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 2.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

Review 3.  Testosterone, myocardial function, and mortality.

Authors:  Vittorio Emanuele Bianchi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 4.  Testosterone, aging and survival: biomarker or deficiency.

Authors:  Molly M Shores; Alvin M Matsumoto
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

5.  Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury.

Authors:  Andrea Soljancic; Arnaldo Lopez Ruiz; Kiran Chandrashekar; Rodrigo Maranon; Ruisheng Liu; Jane F Reckelhoff; Luis A Juncos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

Review 6.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

Review 7.  Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.

Authors:  Kathleen Hwang; Martin Miner
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

Review 8.  Testosterone, cardiomyopathies, and heart failure: a narrative review.

Authors:  Rodica Diaconu; Ionuţ Donoiu; Oana Mirea; Tudor Adrian Bălşeanu
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

Review 9.  Testosterone therapy in the new era of Food and Drug Administration oversight.

Authors:  Bethany Desroches; Taylor P Kohn; Charles Welliver; Alexander W Pastuszak
Journal:  Transl Androl Urol       Date:  2016-04

10.  Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Ahmad Separham; Samad Ghaffari; Bahram Sohrabi; Naser Aslanabadi; Mozhgan Hadavi Bavil; Hasanali Lotfollahi
Journal:  Basic Clin Androl       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.